Drug Utilization Review Act of 1989

Summary

Drug Utilization Review Act of 1989 - Amends part B (Supplementary Medical Insurance) of title XVIII (Medicare) of the Social Security Act to require the establishment of a Drug Utilization Review System (system) providing participating pharmacies, pharmacists, and dispensing physicians with prompt 24-hour electronic access to a medication profile for each Medicare beneficiary for whom they prescribe a covered outpatient drug. Requires that such system identify potential adverse drug reactions that may result from: (1) the interaction of the prescribed drug with other drugs being used by the beneficiary and with a known allergy, physical condition, or illness presented by the beneficiary; and (2) misuse of the prescribed drug. Requires that participating pharmacies, pharmacists, and dispensing physicians having access to the system agree that: (1) no beneficiary will be required to disclose medication profile information as a condition of receiving benefits; (2) the beneficiary's medication profile will not be accessed without the beneficiary's specific and voluntary authorization; (3) data acquired will not be disclosed to anyone other than the beneficiary, except when consultations between those involved in the beneficiary's health care are medically necessary; and (4) each beneficiary shall receive written notice of such requirements. Penalizes, by fine and/or imprisonment, those guilty of the unauthorized disclosure of medication profile information. Authorizes appropriations. Directs the Secretary of Health and Human Services to conduct a study and report to the Congress by October 1, 1992, on the efficacy of expanding the system to include all Medicare-eligible outpatients who are inpatients and information on over-the-counter drugs and biologicals.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 19 April 1989

   Introduced

   Read twice and referred to the Committee on Finance.

   Source: IntroReferral

2. 19 April 1989

   Introduced

   Introduced in Senate

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in Senate · — · Download file

Documents

2 official files

• Introduced in Senate (text)

  Introduced in Senate · EN

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 19 April 1989

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Sen. Wilson, Pete [R-CA] · R · Sponsor
• Sen. Heinz, John [R-PA] · R · Cosponsor
• Sen. Pryor, David H. [D-AR] · D · Cosponsor
• Sen. Stevens, Ted [R-AK] · R · Cosponsor
• Sen. Graham, Bob [D-FL] · D · Cosponsor
• Sen. Cohen, William S. [R-ME] · R · Cosponsor
• · ssfi00 · Standing

Related records

• related to → Drug Utilization Review Act of 1989